Rankings
▼
Calendar
ACRS Q2 2018 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ACRS
Aclaris Therapeutics, Inc.
$407M
Q2 2018 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$4M
Gross Profit
$2M
67.9% margin
Operating Income
-$32M
-869.9% margin
Net Income
-$31M
-849.2% margin
EPS (Diluted)
$-1.01
QoQ Revenue Growth
+228.8%
Cash Flow
Operating Cash Flow
-$22M
Free Cash Flow
-$22M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$202M
Total Liabilities
$28M
Stockholders' Equity
$174M
Cash & Equivalents
$46M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4M
$0
—
Gross Profit
$2M
$0
—
Operating Income
-$32M
-$15M
-109.1%
Net Income
-$31M
-$15M
-110.4%
Revenue Segments
Product
$2M
42%
Laboratory Research Revenue
$1M
31%
Other Revenue
$1M
27%
← FY 2018
All Quarters
Q3 2018 →